| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |